Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05916235 · ClinicalTrials.gov registry record · NA
Photobiomodulation for Management of Temporomandibular Disorder Pain
A NA study of Pain Related to TMD, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT05916235 is a NA study of Pain Related to TMD that is actively recruiting participants, run by University of Florida. The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05916235, a NA study of Pain Related to TMD, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to conduct a clinical trial of multimodal PBM for TMD pain. This study will be a double-blind, sham-controlled, randomized trial testing the efficacy of PBM for pain related to TMD.
Conditions Studied
Interventions
- DEVICE THOR® laser system
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2024-02-08 |
| Est. Completion | 2028-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05916235
The ClinicalTrials.gov registry entry for NCT05916235 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain Related to TMD appearing as the primary indexed condition, and to 1 intervention - of which THOR® laser system is the first listed.
NCT05916235 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT05916235 about?
NCT05916235 is a clinical study titled "Photobiomodulation for Management of Temporomandibular Disorder Pain". Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to conduct a clinical trial of multimodal PBM for TMD pain. This study will be a double-blind, sham-controlled, randomized trial testing the efficacy...
What is the current status of trial NCT05916235?
This trial is currently recruiting. It is a NA study. The enrollment target is 130 participants. The study started on 2024-02-08. Estimated completion is 2028-10.
What conditions does trial NCT05916235 study?
This clinical trial studies the following conditions: Pain Related to TMD.
What interventions are being tested in trial NCT05916235?
The interventions under investigation include: THOR® laser system (DEVICE).
Who is sponsoring clinical trial NCT05916235?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05916235 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.